Thermo Fisher Highlights New FDA-Cleared Diagnostics at ADLM 2026
The company is showcasing newly cleared tests and platforms for multiple myeloma, lung cancer, connective tissue disease, and other laboratory applications.
Latest Articles
Editor's Top Picks
FDA Clears Roche PCR Test for Bacterial Vaginosis and Yeast Infections
The FDA has cleared Roche’s cobas BV/CV assay, a molecular test that detects bacterial vaginosis and Candida vaginitis from a single swab, enabling streamlined diagnosis on the cobas platform, according to Roche.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Countable Labs Launches Program Connecting Researchers With Single-Molecule PCR Services
The program connects researchers with certified laboratories offering single-molecule PCR testing, technical support, and bioinformatics expertise.
Equipment & Supply Spotlight
Roche Receives CE Mark for Tuberculosis Blood Test
The automated assay identifies latent infections in routine laboratory settings with results available in less than 24 hours.
News, Know-How & Standards
Disease Detection & Understanding
Improved Lyme Disease Tests Could Reduce US Healthcare Costs by 41%
New analysis suggests that higher-sensitivity testing could lower annual spending by more than $3 billion by reducing misdiagnosis.
